Alan Genatossio

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 126 citations · Full text

Pharmacy, Pharmacotherapy, Good Clinical Practice +8

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

Félix Ratjen, Stephanie D. Davis, Sanja Stanojevic et al. · The Lancet Respiratory Medicine · 2019 · 115 citations

Pharmacy, Child Health, Pediatrics +11

Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis

Daniel H. Leung, Wen Ye, Jean P. Molleston et al. · The Journal of Pediatrics · 2015 · 49 citations

Medicine, Child Health, Pediatrics +10

Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls

BreAnna Kinghorn, Sharon McNamara, Alan Genatossio et al. · Annals of the American Thoracic Society · 2020 · 48 citations · Full text

Medicine, Clinical Sciences, Pediatrics +17

Sputum Tobramycin Concentrations in Cystic Fibrosis Patients with Repeated Administration of Inhaled Tobramycin

Jennifer Ruddy, Julia Emerson, Richard B. Moss et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2012 · 46 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17